Reirradiation of recurrent medulloblastoma: Does clinical benefit outweigh risk for toxicity?

E-ISSN： 1097-0142|120|23|3731-3737

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.23, 2014-12, pp. : 3731-3737

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Graft versus tumor effect in the brain of a child with recurrent metastatic medulloblastoma

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 9, 2015-09 ,pp. : 1667-1669

John Wiley & Sons Inc

Access to resources Recommend Favorite

Medulloblastoma: Present Concepts of Stratification into Risk Groups

Pediatric Neurosurgery, Vol. 39, Iss. 2, 2003-07 ,pp. : 60-67

Karger

Access to resources Recommend Favorite

Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 2, 2015-06 ,pp. : 129-134

John Wiley & Sons Inc

Access to resources Recommend Favorite

Estimated glomerular filtration rate and the risk–benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial

JOURNAL OF INTERNAL MEDICINE, Vol. 283, Iss. 3, 2018-03 ,pp. : 314-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidental Resolution of a Radiation-Induced Cavernous Hemangioma of the Brain following the Use of Bevacizumab in a Child with Recurrent Medulloblastoma

Pediatric Neurosurgery, Vol. 46, Iss. 4, 2010-12 ,pp. : 303-307

Karger

Access to resources Recommend Favorite